companydata.dkcompanydata.dk

Nordic BioVentures ApS: Financial statements 2024

CVR: 43852116

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Nordic BioVentures ApS (CVR 43852116) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,381,891 and a net result of DKK 265,974 compared with DKK 1,470,607 the year before. That is a decrease of 27.4% compared with the year before. Equity in the 2024 report amounted to DKK 1,736,581. The solvency ratio was 83.5%. The company had 3 employees in the financial year.

Gross Profit
DKK 2,381,891
Profit/Loss
DKK 265,974
Equity
DKK 1,736,581
Total Assets
DKK 2,079,949
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-2.4M266K1.7M3
2023-3.3M1.5M1.5M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Nordic BioVentures ApS publishes interim reportJan 26, 2024

Nordic BioVentures ApS has published its interim report for the period February 6, 2023 to December 31, 2023.

About Nordic BioVentures ApS

Nordic BioVentures ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2023. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Nordic BioVentures 1 AMBA and Nordic BioVentures AMBA. The management consists of Josephine Schrøder Warming and William Comstive Wright Nilsen. The company is owned by Warming Ventures ApS and Wright Ventures ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 1,512,110 and a net result of DKK -1,291,767 compared with DKK 265,974 the year before. Equity in the 2025 report amounted to DKK 444,815.

Source: annual report 2025, Danish Business Authority

Other financial years